“The Effectiveness of Semaglutida in Preventing Cardiovascular Risks Associated With Obesity and Diabetes”. 2025. Revista Eletrônica Acervo Médico 25 (October): e21868. https://doi.org/10.25248/reamed.e21868.2025.